🇺🇸 FDA

Company profile · Sponsor

Beijing

Beijing Anzhen Hospital

C4F464D · NMPA pharma CN
Pipeline
2
Drugs
0
Patents
0

Quick answer

Beijing (C4F464D) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C4F464D
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (2)

Search pipeline →

  1. CYP2C19 genotype testing

    Beijing

    Angina, Stable

    gene therapy active

    1 trial

  2. Corticosteroid

    Beijing

    Heart Valve Diseases

    small molecule completed

    1 trial

Frequently asked questions

What is Beijing?

Beijing (C4F464D) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Beijing sponsor?

We track 2 ClinicalTrials.gov-linked programs for Beijing, including CYP2C19 genotype testing and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Beijing company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.